Testing for fluoxymesterone (Halotestin) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry

J Steroid Biochem. 1990 Aug 28;36(6):659-66. doi: 10.1016/0022-4731(90)90185-u.

Abstract

Fluoxymesterone, an anabolic steroid, is metabolized in man primarily by 6 beta-hydroxylation, 4-ene-reduction, 3-keto-reduction, and 11-hydroxy-oxidation. These pathways of metabolism are suggested by the positive identification of 4 metabolites and the tentative identification of 3 other metabolites. Detection of the drug in urine is possible for at least 5 days after a single 10 mg oral dose to previously untreated adult males, by monitoring the presence of 2 metabolites, since the parent drug is not detectable more than 1 day after the dose.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Fluoxymesterone / metabolism
  • Fluoxymesterone / pharmacokinetics*
  • Fluoxymesterone / urine
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Male
  • Models, Biological
  • Substance-Related Disorders / urine

Substances

  • Fluoxymesterone